Marketplace
For Industry Partners
For Innovators
Contact sales
Sign in
Join now
TS
Talia Cohen Solal
CEO
NeuroKaire
Publications
20
Funding
0
Patents
0
Inhibitors of central nervous system vasoactive inhibitory peptide receptor 2
US Patent App. 14/707,981, 2015
The DISC1Cys607Phe polymorphism affects mitochondrial transport in neurons
Molecular Psychiatry 16 (2), 121-121, 2011
Using Patient iPSC-Derived Neurons to Uncover Mechanisms Associated with Response to Antidepressant Drugs: A Framework for Precision Medicine in Depression
CNS Spectrums 29 (5), 484-484, 2024
Methods of therapeutic prognostication
US Patent App. 17/800,096, 2023
Patient iPSC-derived neurons reveal mechanisms underlying antidepressant response: a potential diagnostic tool
European Psychiatry 66 (S1), S92-S93, 2023
Comprehensive High-Throughput Drug Screening in a Cellular Model of KCNQ2 Epileptic Encephalopathy
ANNALS OF NEUROLOGY 82, S297-S297, 2017
Small Molecule Antagonists of the VPAC2 Receptor as a Novel Direction for Schizophrenia Therapeutics
NEUROPSYCHOPHARMACOLOGY 40, S380-S380, 2015
Using hIPSCs to Model Disease Mechanisms in Schizophrenia
NEUROPSYCHOPHARMACOLOGY 39, S314-S315, 2014
Neuronal Mitochondrial Transport and Dysfunction
Mitochondrial Dysfunction in Neurodegenerative Disorders, 157-173, 2012
Investigating the role of Disrupted-in-Schizophrenia 1 in neuronal function and disease
UCL (University College London), 2011
Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells
Nature biotechnology 35 (2), 154-163, 2017
Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses
European Journal of Neuroscience 32 (2), 231-240, 2010
DISC1-dependent regulation of mitochondrial dynamics controls the morphogenesis of complex neuronal dendrites
Journal of Biological Chemistry 291 (2), 613-629, 2016
Disrupted in Schizophrenia-1 regulates intracellular trafficking of mitochondria in neurons
Molecular psychiatry 16 (2), 122-124, 2011
Disrupted in Schizophrenia 1 forms pathological aggresomes that disrupt its function in intracellular transport
Human molecular genetics 21 (9), 2017-2028, 2012
A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsy
Epilepsia 59 (4), 802-813, 2018
Cobalt (III) protoporphyrin activates the DGCR8 protein and can compensate microRNA processing deficiency
Chemistry & biology 22 (6), 793-802, 2015
Depression patient-derived cortical neurons reveal potential biomarkers for antidepressant response
Translational Psychiatry 11 (1), 201, 2021
DISC1 and the aggresome: a disruption to cellular function?
Autophagy 8 (5), 851-852, 2012
Genetika+: precision medicine solutions for mental health
Pharmacogenomics 23 (10), 571-574, 2022
TS
Talia Cohen Solal
CEO
NeuroKaire
Work experience
NeuroKaire
CEO
Instituto de Investigaciones en Ingeniería Genética y Biología Molecular, INGEBI-CONICET
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Open to opportunities in
Cognitive Neuroscience
Neuropathology
Neuropharmacology
Last updated Jan 2025
Report Error
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
Subscribe
Company
About
Blog
Careers
Halo Awards
Support
FAQs
Help center
Feature requests
Contact support
Sponsors
Customer stories
Privacy Policy
Terms of Service
© 2026 Halo Cures, Inc.